 |  |  | Current Jobs | Not displayed, CONTACT the Zenopa Account Manager Jo-Anne on 01494 818 012 or jo@zenopa.com for CURRENT and future vacancies.
| |
|  | Actelion Pharmaceuticals UK Ltd Jobs Profile | Company Overview
Actelion's business momentum is mirrored in the growing number of its employees. Our staff represent the best professional attributes, blending biotech innovation with pharmaceutical discipline and the highest ethical standards.
As part of our strategy, we continue to place a high priority on attracting, developing and retaining highly talented people. Employees who identify with the goals and values of our company have transformed the vision of Actelion's founders into reality: People with passion and expertise are paving the way to our future success. |
At Actelion, people make the differenceThroughout its years of rapid growth, Actelion has always been highly conscious of the fact that it's people who make the difference. In turn, we have made sure our employees understand that we expect each of them to make a significant contribution. Actelion acknowledges that people come to us from diverse backgrounds, both culturally and professionally. We strive to provide our employees with the best environment in which they can fulfill their individual aspirations and contribute to innovative medicines that positively affect patients' lives. Actelion's CEO, Jean-Paul Clozel, spends a considerable amount of his time working to foster a corporate culture in which innovation is the focus. As a company, we have defined the professional development of our employees as a strategic priority. On a day-to-day basis, we undertake substantial improvements in infrastructure and the services provided to our rapidly expanding workforce. In this way, we can ensure a well-resourced environment conducive to optimal productivity. |
|  |
|
|  | Jo-Anne
Actelion Pharmaceuticals UK Ltd Account Manager
01494 818 012
(Mon to Fri 0830 to 1800 hours)
jo@zenopa.com
| |
| Company Reports | 31/12/2007 Accounts
You need to be logged in to view these reports, please login first then return to this page. | |
|
